Serum ultrafiltrable copper, total copper and caeruloplasmin concentrations in gynaecological carcinomas
Serum copper and caeruloplasmin concentrations are elevated in various carcinomas, but it is not known whether the rise in serum copper is due to elevation of caeruloplasmin alone or whether it is also due to the elevation of 'free' copper. We therefore determined ultrafiltrable copper to answer this question. Serum ultrafiltrate was prepared using the Amicon micropartition system and ultrafiltrable (free) copper was determined by flameless atomic absorption spectrophotometry. Serum total copper was determined by flame atomic absorption spectrometry and caeruloplasmin by rate nephelometry. There was no significant difference in the ultrafiltrable copper concentration between patients with gynaecological tumours and control subjects. However, total copper and caeruloplasmin concentrations were significantly elevated in cancer patients compared with control subjects. In contrast to total copper and caeruloplasmin concentrations, ultrafiltrable copper concentrations showed no significant increase with increase in the stage of the cancer.
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Serum copper concentration has been shown to be elevated in haematologic and lymphatic malignancies such as leukaemias' and lymphomasand in patients with solid tumours such as sarcomas.! bronchogenic carcinoma" and melanoma. S Elevated levels have also described in patients with gynaecological tumours including carcinoma of cervix, ovary and endornetrium.v'? The level of serum copper increased with the severity of the disease, and decreased after successful treatment. Serum caeruloplasmin concentration has been reported to be elevated in various malignancies such as carcinoma of the breast, cervix and vulva.P Studies of the distribution of copper among various human serum components have demonstrated that caeruloplasmin, transcuprein, albumin and low-molecular-weightcopper fractions account for about 65(11)0/0, 14(2)%, 14(4)% and 8(5)% [mean (2SD) l oftotai serum copper, respectively.
A small proportion, less than 5%, circulates as non-protein-bound 'free' copper which is readily available for uptake by cells.'! As various factors could alter the concentration of copper and Correspondence: Dr Mano Arumanayagam.
copper-binding proteins, estimation of the free fraction of copper might provide valuable information. In addition, it is not known whether the rise in serum copper is due simply to a rise in caeruloplasmin copper or whether it is due to an increase in the free copper as well.
The study designed was to examine whether the free fraction of copper was increased in carcinoma of cervix and ovary, and to determine its relationship to the International Federation of Gynecology and Obstetrics (FIGO) stage, which is based on the extent of spread of cancer, both clinically and histologically. 12 
MATERIALS AND METHODS
All chemicals were of analytical grade and were obtained from BDH chemicals Ltd (Dorset, UK), except for copper standard solution which was from Sigma Chemical Company (St Louis, MO, USA). Amicon Micropartition System (MPS-l) was obtained from Amicon Inc. (Beverly, MA, USA). Pathonorm Land Seronorm were purchased from Nycomed AS (Oslo, Norway). Caeruloplasmin kit was a kind gift from Beckman (HK) Ltd (Hong Kong). All sample tubes, cryofuge tubes, autosample cups, pipette tips and glassware used in this study were washed by immersion in dilute nitric acid (2 mol/L) for 24 h and rinsed six times with deionized water. Serum total copper was determined by flame atomic absorption spectrophotometry (Varian AA-40 Spectrophotometer, Varian Techtron Pty Ltd, Melbourne, Australia) following dilution of plasma (0' 5 mL) with 1. 5 mL of deionized water. Pathonorm L and Seronorm were used as quality control material. Serum caeruloplasmin was measured by rate nephelometry using the Beckman Array'?' Protein System (Beckman Instruments Inc, Brea, CA, USA) using calibrators, quality control material and buffers obtained from the same company.
Serum ultrafiltrate was obtained by centrifugation (at 1800 g for 30 min at room temperature) using the Amicon Micropartition System with YMT membranes (molecular weight cut-off 30 kDa). Macromolecular components larger than the membrane pores were quantitively retained above the membrane while ultrafiltrate containing the non-protein-bound copper fraction collected in the pre-washed filtrate cup. The protein concentration in the ultrafiltrate was determined by the Coomassie brilliant blue method. I] Quantitation of the ultrafiltrable copper was by flameless atomic absorption spectrophotometry using the standard addition method on a Varian Spectraa/3OO/4oo Spectrophotometer (Varian Techtron Pty Ltd, Melbourne, Australia) equipped with a GTA-96 graphite tube atomizer for volatization and atomilization. The furnace parameters are shown in Table 1 .
In this method, the peak absorbance of the sample (10 ",L) was measured. In identical samples, two aqueous copper standards (0' 5 and 1·0 ",mol/L) were added and peak absorbance was measured again. The peak absorbance was Ann Clin Biochem 1993: 30 plotted against the concentration of the added copper standard and the concentration of copper in the ultrafiltrate was determined from the intercept on the x axis.
Method evaluation for ultrafiltrable copper
The within-run precision (coefficient of variation, CV) ranged from 2· 50/0 to 7· 5% at three different levels. For the between-day precision the range was 4·0% to 8·7% (Table 2) . Two different concentrations of copper standard (0' 5 and 1. 0 ",mol/L) were added to an aliquot of the ultrafiltrate. The copper contents were determined before and after the added standard and the percentage recovery was calculated. The median recovery was 100·4% and the range 95'8% to 106'6%. The lower detection limit was O' 05 ",mol/L as the CV at this concentration was about 7%; at 0·025 ",mol/L, the CV was 9'5%. The method was linear to 1. 2 ",mol/L of copper.
Serum samples collected from six healthy subjects were analysed immediately. The remainder was aliquoted into polypropylene cryofuge tubes and stored at 4°C, -lO°C and -70°C for 31 and 62 days. The serum was removed, brought to 37°C for 30 min, the ultrafiltrate prepared and the copper concentration determined and compared with that of the fresh sample.
The ultrafiltrable copper concentration remained unchanged when samples were stored at -70°C for up to 62 days (no significant difference by Wilcoxon's rank sum test). However, the ultrafiltrable copper concentration decreased by 40 and 60% when samples were stored at 4°C and -20°C for >31 days, respectively.
Statistics
Since it was not possible to ascertain departures from a Gaussian distribution due to the small one-way analysis of variance was used to compare three or more groups of subjects. Precision data are given as mean, SD and CV. All data were analysed using the Abstat" computer program.
PATIENTS
Nineteen patients with carcinoma of cervix (age 29 to 80) and four with carcinoma of the ovary (age 18 to 68) were studied. Control subjects n = 19) were healthy laboratory female staff age 21-43 none of whom were taking any medication including oral contraceptives. Venous blood was collected from each subject into plain tubes. Serum was separated and stored at -70 D C and analysed within 1 month.
RESULTS
The protein content in the ultrafiltrates was less than 26 mg/L; less than O' 1070 of the total protein. Out of a total of 2DO, two membranes were found to leak as the protein concentration was found to be greater than 30 mg/L and these samples were discarded. Thus the calculated percentage of membrane leakage was 1·0070. Table 3 summarizes the results of total copper, ultrafiltrable copper and caeruloplasmin concentration in patients and control subjects. There
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was no significant difference in the ultrafiltrable copper concentration in the patients with cervical cancer compared to control subjects. The total copper and caeruloplasmin concentration of patients with cancer of cervix were significantly higher (P<0·D01) than that of the control subjects. Although, there were only four patients with cancer of the ovary, the results of ultrafiltrable and total copper, and caeruloplasmin were similar to those in patients with cancer of the cervix. The relationship between total copper and caeruloplasmin is illustrated in Fig. I 
DISCUSSION
The Amicon MPS-l micropartition system is an efficient ultrafiltration method for separating microsolute from the protein-bound fraction. The method is rapid, easy to perform and can be used .. = patients. • .
-.. routinely. For every 1 mL of serum, about 400 to 450 JLL of ultrafiltrate was obtained. A small proportion of the membranes (1070) leaked protein but this leakage was obvious from protein determinations on the ultrafiltrate. The exact physiological role of ultrafiltrable copper in pathological states is not known. An important part of this study was to evaluate the relationship of ultrafiltrable copper with total copper and caeruloplasmin concentration. However, there was no significant difference in the ultrafiltrable copper concentration between patients with carcinoma of cervix and ovary, and control subjects. Furthermore, ultrafiltrable copper showed no significant correlation with either caeruloplasmin or total copper. This suggests a regulatory mechanism for the free copper concentration in blood different from that governing caeruloplasmin-bound and other copper-containing fractions.
This study confirms earlier findings/-? that the concentrations of total copper and caeruloplasmin are significantly elevated in patients with gynaecological tumours. The CC between copper and caeruloplasmin was O·928, suggesting that the copper:caeruloplasmin ratio was constant. A similar correlation (r = O·878) was found by Brandes et al. ' These findings are also in agreement with Lightman et al. 8 who found that the serum and tissue copper concentrations were significantly increased in malignant ovarian tumours. Linder et al.
14 have suggested that the increase of serum caeruloplasmin in rats into transplanted tumours was mainly due to increased synthesis by the liver. Fisher and Shifrme" suggested that decreased catabolism due to resialylation of sialocaeruloplasmin could account for such increases. Normal catabolism of caeruloplasmin in the liver follows desialylation. However, in patients with tumours caeruloplasmin may be resialylated at the tumour cell surface or in peripheral blood." On the other hand the increase in caeruloplasmin concentration may be an acute phase reaction because caeruloplasmin is a known acute phase protein;" Therefore, the mechanism of the increase of copper and caeruloplasmin in humans is not known.
In this study, the percentage of ultrafiltrable copper in both patients and controls were less than 1010 of the total copper concentration. This is in agreement with reported values using the MPS-l system'? and chromatographic techniques.Jl-''' In contrast, caeruloplasmin and total copper concentration differed significantly between the two groups of subjects. These findings suggest that in gynaecological carcinomas, it is mainly changes in caeruloplasmin concentration that induce variation in total copper concentration. It is postulated that it is ultrafiltrable copper that is available for uptake by cells for intracellular functions. Thus, the absence of any change in ultrafiltrable copper in gynaecological carcinoma suggests that the bioavailable copper is unaltered.
In accordance with previous findings;" total copper and caeruloplasmin concentration were raised with the FlGO stage of cervical carcinoma. However, there was no increase in the ultrafiltrable copper concentration with the FIOO stage of cancer. The FIOO staging of cervical cancer is based on clinical examination and histological evidence, but it does not reflect tumour size. In addition, plasma total copper concentration may not reflect the tissue content in cancer patients. Therefore, further evaluation of tissue copper in cervical cancer may reflect tissue requirement of this trace element and its relationship to clinical stage of disease.
In conclusion, the ultrafiltrable (free) copper concentration was similar in cancer patients and control subjects. However, serum total copper and caeruloplasmin concentrations were significantly higher in patients with gynaecological tumours (cervix and ovary), showing that the rise of total copper concentration is entirely due to elevation of caeruloplasmin concentration.
